Bahareh Dabirmanesh

Dr. Bahareh Dabirmanesh


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SKShima Khodaverdian
Shima Khodaverdian
BDBahareh Dabirmanesh
Bahareh Dabirmanesh
AHAkbar Heydari
Akbar Heydari
EDElahe Dashtban-Moghadam
Elahe Dashtban-Moghadam
KKKhosro Khajeh
Khosro Khajeh
FGFarideh Ghazi
Farideh Ghazi

11 June 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SHShokouh Honarmand
Shokouh Honarmand
BDBahareh Dabirmanesh
Bahareh Dabirmanesh
MAMassoud Amanlou
Massoud Amanlou
KKKhosro Khajeh
Khosro Khajeh
Proteins from their native conformation convert into highly ordered fibrillar aggregation under particular conditions; that are described as amyloid fibrils. α-Synuclein (α-Syn) is a small natively unfolded protein that its fibrillation is the causative factor of Parkinson’s disease. One important approach in the development of therapeutic agents is the use of small molecules (such as flavonoids) that could specifically and efficiently inhibit the aggregation process. In this study the effect of few herbal extract (Berberis, Quercus robur, Zizyphus vulgaris, Salix aegyptica) containing flavonoids were investigated on fibril formation of α-syn by using conventional methods such as ThT fluorescence, circular dichroism (CD) spectroscopy and transmission electron microscopy (TEM). The interaction of extracts were also analysed by surface plasmon resonance (SPR). Among extracts, Salix aegyptica revealed the highest inhibitory effect on fibril formation. As expected, Salix aegyptica extract also exhibited the highest affinity toward α-syn. Cell viability using MTT assay revealed that fibrils alone were more toxic than those containing the extract. Overall, we demonstrated that the affinity of compounds used in this study corresponds to their ability to arrest fibrillation and reduce cellular toxicity of α-syn fibrils.

1 June 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
AKAtefeh Khodakarami
Atefeh Khodakarami
NGNegar Goodarzi
Negar Goodarzi
MHMahshideh Hoseinzadehdehkordi
Mahshideh Hoseinzadehdehkordi
FAFezzeh Amani
Fezzeh Amani
SKShima Khodaverdian
Shima Khodaverdian
BDBahareh Dabirmanesh
Bahareh Dabirmanesh

20 August 2024 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
FSFereshte sadat Sabet
Fereshte sadat Sabet
BDBahareh Dabirmanesh
Bahareh Dabirmanesh
HSHoorie Sadat Sabet
Hoorie Sadat Sabet
PZParisa Zarei
Parisa Zarei
Morteza HosseiniMorteza Hosseini
Morteza Hosseini
KKKhosro Khajeh
Khosro Khajeh

1 November 2015 in Journal of Molecular Catalysis B: Enzymatic
Verified
Journal Article
Closed access
SJSafoura Jabbari
Safoura Jabbari
BDBahareh Dabirmanesh
Bahareh Dabirmanesh
KKKhosro Khajeh
Khosro Khajeh

16 July 2020 in Biological Chemistry
Verified
Journal Article
Closed access
PDF file
NMNarges Marvastizadeh
Narges Marvastizadeh
BDBahareh Dabirmanesh
Bahareh Dabirmanesh
RSReza H. Sajedi
Reza H. Sajedi
KKKhosro Khajeh
Khosro Khajeh
α-Synuclein fibrillation is now regarded as a major pathogenic process in Parkinson’s disease and its proteinaceous deposits are also detected in other neurological disorders including Alzheimer's disease. Therefore anti-amyloidegenic compounds may delay or prevent the progression of synucleinopathies disease. Molecular chaperones are group of proteins which mediate correct folding of proteins by preventing unsuitable interactions which may lead to aggregation. The objective of this study was to investigate the anti-amyloidogenic effect of molecular chaperone artemin on α-synuclein. As the concentration of artemin was increased up to 4 μg/ml, a decrease in fibril formation of α-synuclein was observed using thioflavin T (ThT) fluorescence and congo red (CR) assay. Transmission electron microscopy (TEM) images also demonstrated a reduction in fibrils in the presence of artemin. The secondary structure of α-synuclein was similar to its native form prior to fibrillation when incubated with artemin. A cell-based assay has shown that artemin inhibits α-synuclein aggregation and reduce cytotoxicity, apoptosis and reactive oxygen species (ROS) production. Our results revealed that artemin has efficient chaperon activity for preventing α-synuclein fibril formation and toxicity.